Hillcrest Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-161,162
Closed -$11.8M 60
2020
Q1
$11.8M Buy
161,162
+1,060
+0.7% +$92K 2.84% 9
2019
Q4
$13.5M Sell
160,102
-5,788
-3% -$448K 2.05% 17
2019
Q3
$13.9M Sell
165,890
-4,980
-3% -$376K 2.23% 11
2019
Q2
$11.2M Buy
170,870
+1,030
+0.6% +$59.4K 1.74% 32
2019
Q1
$10M Buy
169,840
+44,852
+36% +$2.68M 1.6% 35
2018
Q4
$6.62M Buy
124,988
+30
+0% +$1.65K 1.59% 40
2018
Q3
$7.49M Buy
+124,958
New +$6.83M 1.42% 47

Other funds holding MEDP

Hillcrest Asset Management's MEDP Position: Q2 2020 in Review

Hillcrest Asset Management sold out of Medpace (MEDP) in Q2 2020, closing a stake of 161,162 shares — an estimated $11.8M sold.

Hillcrest Asset Management first reported a position in MEDP in Q3 2018 and held it in 7 quarters. The position peaked at $13.9M in Q3 2019. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

  • Hillcrest Asset Management reported no remaining Medpace position as of Q2 2020 after selling out during the quarter.
  • Hillcrest Asset Management sold 161,162 Medpace shares in Q2 2020, an estimated $11.8M.
  • Hillcrest Asset Management first reported a position in Medpace in Q3 2018 and held it in 7 quarters.
  • Hillcrest Asset Management's Medpace position peaked at $13.9M in Q3 2019.
  • 277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on Hillcrest Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.